Close

Sign in
Sign up

Menu

Data Search
Content
Startup Concierge
Newsletters
Get intel

Home
News
Hemab announced a $135 million Series B financing led by Access Biotechnology

Hemab announced a $135 million Series B financing led by Access Biotechnology

Biotech Health services

Denmark

Sweden

United States

Investments

17 February 2023

Share:

Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!

Hemab (company)

Denmark

Biotech Health services

Total investments received (USD): 347M

Round value (USD): 135M

Round investors: HealthCap Novo A/S Deep Track Capital Access Biotechnology Avoro Ventures Rock Springs Capital Maj Invest RA Capital Management Invus

Company: Hemab

Industry: Biotech Health services

Related deals

Hemab raised $157m Series C led by Sofinnova, joined by Avoro Capital, RA Capital, Novo, Access Biotechnology, Deep Track, HealthCap, Invus, Maj Invest

Biotech Health services

Denmark

Sweden

France

United States

Investments 16 October 2025

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2025. Made with in Stockholm

Top